RNA logo

RNA
Atrium Therapeutics Inc.

1,594
Mkt Cap
$230.87M
Volume
196,598.00
52W High
$16.77
52W Low
$11.95
Price
$13.49
RNA Fundamentals
Prev Close
$13.85
Open
$13.78
50D MA
$13.92
Beta
0.00
Avg. Volume
1.02M
EPS (Annual)
-$2.89
P/B
-3.68
Loading...
Loading...

About

Atrium Therapeutics, Inc. operates as a biopharmaceutical company that provides RNA therapeutics services to the heart to transform the standard of care for people living with cardiomyopathies. Its products pipeline includes two lead development candidates: ATR 1072 for PRKAG2 syndrome and ATR 1086 for PLN cardiomyopathy, both conditions are severe, life-threatening, rare autosomal dominant progressive cardiomyopathies with no approved treatment options and high unmet need. The company was founded on September 30, 2025 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Atrium Therapeutics Inc.?
What is the 52-week high for Atrium Therapeutics Inc.?
What is the 52-week low for Atrium Therapeutics Inc.?
What is Atrium Therapeutics Inc. stock price today?
What was Atrium Therapeutics Inc. stock price yesterday?
What is the Price-to-Book ratio of Atrium Therapeutics Inc.?
What is the 50-day moving average of Atrium Therapeutics Inc.?

Latest RNA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.